Literature DB >> 6782963

Mannitol.

S E Warren, R C Blantz.   

Abstract

Mannitol is an osmotic diuretic with properties that suit it to a variety of clinical situations. Despite the paucity of controlled studies that precisely define optimal use, a consensus based on published work and clinical experience may be reached. Mannitol can be used prophylactically, as a diagnostic aid, or as therapy for the oliguric state. The diuretic properties of mannitol are also useful in patients with refractory edema or intoxications by aspirin, barbiturates, or bromide. As an extracellular solute, the drug may ameliorate intracranial hypertension or symptoms of dialysis dysequilibrium. The renal and systemic effects of this versatile agent are discussed.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6782963

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  9 in total

1.  Dilution acidosis and an increase of P(A-a)O2 during transurethral resection of the prostate.

Authors:  T Harioka; H Toda; C Miyake
Journal:  J Anesth       Date:  1989-03-01       Impact factor: 2.078

2.  Differences in metabolomic profiles of male db/db and s/s, leptin receptor mutant mice.

Authors:  Nadia Saadat; Heidi B IglayReger; Martin G Myers; Peter Bodary; Smiti V Gupta
Journal:  Physiol Genomics       Date:  2012-02-07       Impact factor: 3.107

Review 3.  Diuretic response in acute heart failure-pathophysiology, evaluation, and therapy.

Authors:  Jozine M ter Maaten; Mattia A E Valente; Kevin Damman; Hans L Hillege; Gerjan Navis; Adriaan A Voors
Journal:  Nat Rev Cardiol       Date:  2015-01-06       Impact factor: 32.419

4.  Investigation of intravascular haemolysis during treatment of acute stroke with intravenous glycerol.

Authors:  C R Kumana; G T Chan; Y L Yu; I J Lauder; T K Chan; M Kou
Journal:  Br J Clin Pharmacol       Date:  1990-03       Impact factor: 4.335

5.  Potassium sparing diuretics as adjunct to mannitol therapy in neurocritical care patients with cerebral edema: effects on potassium homeostasis and cardiac arrhythmias.

Authors:  Federico Bilotta; Federico Giovannini; Flavia Aghilone; Elisabetta Stazi; Luca Titi; Ivan Orlando Zeppa; Giovanni Rosa
Journal:  Neurocrit Care       Date:  2012-04       Impact factor: 3.210

6.  Level and determinants of kidney function in a South Asian population in Pakistan.

Authors:  Tazeen H Jafar; Muhammad Islam; Saleem Jessani; Rasool Bux; Lesley A Inker; Christophe Mariat; Andrew S Levey
Journal:  Am J Kidney Dis       Date:  2011-08-15       Impact factor: 8.860

7.  The use of mannitol in partial and live donor nephrectomy: an international survey.

Authors:  M Cosentino; A Breda; F Sanguedolce; J Landman; J-U Stolzenburg; P Verze; J Rassweiler; H Van Poppel; H C Klingler; G Janetschek; A Celia; F J Kim; G Thalmann; U Nagele; A Mogorovich; C Bolenz; T Knoll; F Porpiglia; M Alvarez-Maestro; F Francesca; F Deho; S Eggener; C Abbou; M V Meng; M Aron; P Laguna; D Mladenov; A D'Addessi; P Bove; R Schiavina; O De Cobelli; A S Merseburger; O Dalpiaz; F C H D'Ancona; T J Polascik; R Muschter; T J Leppert; H Villavicencio
Journal:  World J Urol       Date:  2012-12-15       Impact factor: 4.226

Review 8.  Clinical pharmacokinetic considerations in the treatment of increased intracranial pressure.

Authors:  G Heinemeyer
Journal:  Clin Pharmacokinet       Date:  1987-07       Impact factor: 6.447

Review 9.  The altered pharmacokinetics and pharmacodynamics of drugs commonly used in critically ill patients.

Authors:  A Bodenham; M P Shelly; G R Park
Journal:  Clin Pharmacokinet       Date:  1988-06       Impact factor: 6.447

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.